MobilEye Global Inc vs Twist Bioscience Corp — how do they compare? MobilEye Global Inc trades at $8.9 (market cap $7.54B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: MobilEye Global Inc and Twist Bioscience Corp are close in size by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals.
| MBLY | TWST | |
|---|---|---|
Market Cap | $7.54B | $7.72B |
Sector | Technology | Health |
52-Week High | $15.54 | $124.88 |
52-Week Low | $6.56 | $24.16 |
Enterprise Value | $6.10B | $7.65B |
Trailing returns across standard periods
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →